The data obtained from this study is useful to verify the reliability of ICAM-1 and VCAM-1 as SLE disease monitoring and flare predictor tools and the potential of anti-C1q antibody as SLE global activity biomarker [19]. The gene discussed is ICAM1; the disease is systemic lupus erythematosus.